Bioventus Faces Competitive Landscape in Medical Devices

Bioventus, a North Carolina-based medical device company, competes with 27 other public firms in the surgical and medical instruments industry.

Mar. 8, 2026 at 7:08am

Bioventus (NASDAQ:BVS) is a medical device company focused on developing and commercializing treatments that engage the body's natural healing process. The company operates in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, competing with 27 other public firms. While Bioventus has higher revenue than its competitors, it has lower earnings per share and trades at a higher price-to-earnings ratio, indicating it may be more expensive than other companies in the industry.

Why it matters

The analysis of Bioventus and its competitors provides insight into the competitive landscape of the medical devices industry. Factors like profitability, valuation, institutional ownership, and volatility can impact a company's long-term growth and success, making this comparison relevant for investors and industry observers.

The details

Bioventus' portfolio includes pain treatments, surgical solutions, and restorative therapies for the orthopedic market. The company serves physicians across various specialties in clinics, ambulatory surgical centers, and hospitals. While Bioventus has higher revenue than its peers, it lags in earnings per share and trades at a higher valuation. Analysts believe Bioventus' competitors have more favorable growth aspects. Bioventus also has stronger institutional ownership and insider ownership compared to the industry average, which can signal confidence in the company's prospects.

  • Bioventus was founded in 2011 and is headquartered in Durham, North Carolina.

The players

Bioventus Inc.

A medical device company that focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally.

Surgical, Medical, And Dental Instruments And Supplies industry

The industry that Bioventus operates in, which includes 27 other public companies.

Got photos? Submit your photos here. ›

The takeaway

Bioventus faces a competitive landscape in the medical devices industry, with 27 other public companies operating in the same space. While the company has higher revenue, it lags in profitability and trades at a premium valuation compared to its peers. Investors and industry observers will want to closely monitor Bioventus' ability to differentiate itself and drive long-term growth in this crowded market.